bf/NASDAQ:EKSO_icon.jpeg

NASDAQ:EKSO

Ekso Bionics Holdings, Inc.

  • Stock

USD

Last Close

1.33

26/07 18:10

Market Cap

19.73M

Beta: 1.81

Volume Today

20.25K

Avg: 23.20K

PE Ratio

−2.21

PFCF: −2.71

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
5.33M
-
8.66M
62.59%
14.22M
64.20%
7.35M
48.29%
11.33M
54.11%
13.92M
22.81%
8.88M
36.18%
11.25M
26.62%
12.91M
14.81%
18.28M
41.57%
cost of revenue
3.77M
-
7.48M
98.57%
11.27M
50.68%
5.28M
53.13%
7.02M
32.91%
7.15M
1.85%
3.81M
46.71%
4.50M
17.97%
6.70M
48.94%
8.58M
28.11%
gross profit
1.56M
-
1.18M
24.37%
2.95M
149.96%
2.07M
29.79%
4.31M
108.26%
6.76M
56.97%
5.07M
25.04%
6.75M
33.12%
6.21M
7.93%
9.70M
56.07%
selling and marketing expenses
7.08M
-
9.26M
30.67%
11.00M
18.78%
13.16M
19.63%
13.83M
5.10%
11.40M
17.57%
7.75M
31.99%
7.30M
5.77%
7.16M
2.03%
8.47M
18.37%
general and administrative expenses
7.40M
-
7.00M
5.38%
10.85M
55.00%
10.71M
1.27%
11.70M
9.19%
7.41M
36.68%
7.70M
3.95%
10.52M
36.64%
10.99M
4.40%
10.69M
2.67%
selling general and administrative expenses
14.48M
-
16.26M
12.25%
21.85M
34.38%
23.87M
9.25%
25.53M
6.94%
18.81M
26.33%
15.45M
17.83%
17.83M
15.37%
18.14M
1.77%
19.17M
5.63%
research and development expenses
3.87M
-
6.48M
67.53%
8.88M
37.02%
9.48M
6.80%
5.85M
38.34%
4.60M
21.40%
2.47M
46.17%
2.75M
11.08%
3.63M
31.95%
5.03M
38.58%
other expenses
-61K
-
-45K
26.23%
-166K
268.89%
296K
278.31%
-425K
243.58%
-132K
68.94%
990K
850%
-884K
189.29%
-30K
96.61%
-619K
1,963.33%
cost and expenses
22.12M
-
30.22M
36.62%
42.00M
38.98%
38.64M
8.01%
38.40M
0.62%
30.56M
20.42%
21.74M
28.85%
25.07M
15.34%
28.47M
13.54%
33.39M
17.29%
operating expenses
18.35M
-
22.74M
23.90%
30.73M
35.13%
33.35M
8.54%
31.37M
5.94%
23.40M
25.41%
17.93M
23.39%
20.58M
14.78%
21.77M
5.80%
24.81M
13.96%
interest expense
435K
-
13K
97.01%
170K
1,207.69%
648K
281.18%
600K
7.41%
384K
36%
139K
63.80%
113K
18.71%
156K
38.05%
302K
93.59%
ebitda
-16.85M
-
-21.59M
28.17%
-32.26M
49.40%
-29.26M
9.32%
-27.49M
6.04%
-17.87M
35.01%
-11.58M
35.20%
-14.71M
27.08%
-15.59M
5.94%
-13.41M
13.94%
operating income
-16.79M
-
-21.56M
28.39%
-27.59M
27.94%
-31.61M
14.59%
-27.03M
14.49%
-16.64M
38.44%
-12.86M
22.72%
-13.83M
7.54%
-15.56M
12.50%
-15.11M
2.85%
depreciation and amortization
745K
-
933K
25.23%
1.85M
98.82%
1.73M
6.63%
1.51M
12.53%
-1.23M
181.06%
1.28M
204.32%
-884K
169.01%
-30K
96.61%
1.70M
5,760%
total other income expenses net
-16.55M
-
1.97M
111.92%
4.48M
127.17%
2.81M
37.28%
673K
76.06%
4.51M
569.69%
-2.97M
165.83%
4.06M
236.97%
476K
88.29%
-86K
118.07%
income before tax
-33.77M
-
-19.59M
41.99%
-23.47M
19.81%
-29.12M
24.08%
-26.99M
7.31%
-12.13M
55.05%
-15.82M
30.44%
-9.76M
38.30%
-15.08M
54.44%
-15.20M
0.78%
income tax expense
-371K
-
-965K
160.11%
-6.17M
539.07%
944K
115.31%
1.27M
34.85%
-438K
134.41%
1.13M
357.76%
-1.33M
217.98%
-476K
64.26%
net income
-33.77M
-
-19.59M
41.99%
-23.47M
19.81%
-29.12M
24.08%
-26.99M
7.31%
-11.69M
56.68%
-16.95M
44.98%
-8.43M
50.27%
-14.60M
73.20%
-15.20M
4.07%
weighted average shs out
965.88K
-
1.26M
30.63%
1.21M
4.23%
2.37M
96.45%
4.08M
71.95%
4.79M
17.45%
7.16M
49.43%
12.19M
70.20%
12.96M
6.31%
13.87M
6.98%
weighted average shs out dil
965.88K
-
1.26M
30.66%
1.24M
1.63%
2.37M
91.22%
4.08M
71.95%
4.79M
17.45%
7.16M
49.43%
12.27M
71.26%
12.96M
5.65%
13.87M
6.98%
eps
-34.96
-
-15.53
55.58%
-19.42
25.05%
-12.27
36.82%
-6.61
46.13%
-2.44
63.09%
-2.37
2.87%
-0.69
70.89%
-1.13
63.77%
-1.10
2.65%
epsdiluted
-34.96
-
-15.52
55.61%
-18.90
21.78%
-12.27
35.08%
-6.61
46.13%
-2.44
63.09%
-2.37
2.87%
-0.69
70.89%
-1.13
63.77%
-1.10
2.65%

All numbers in USD (except ratios and percentages)